Follicular Lymphoma Foundation
At a glance
Key takeaways
- This foundation funds research into follicular lymphoma, so it fits only if your work is directly about that blood cancer.
- Its CURE FL awards favour pre-clinical and early-phase research, particularly cellular immunotherapy and targeted therapies, with a route into clinical trials or near-term patient treatment.
- Its FL Biomarker Discovery Program has a stated figure of up to $350,000 for that single programme, but no grant range is given, so do not take that as a typical request.
- No application process is published, so contact the foundation first to ask how to begin, and show how your proposal aligns with patient needs and interests, since reviews draw on global experts and people living with FL.
- Organisations whose work is not follicular lymphoma research should not apply.
Overview
Follicular Lymphoma Foundation is a charity registered with the Charity Commission for England and Wales (charity number 1185091).
The Follicular Lymphoma Foundation exists to help people with follicular lymphoma, a currently incurable blood cancer, to live well and get well by finding and funding research that could change how the condition is understood and treated. It runs three programmes: the CURE FL Awards and Research United to CURE FL Awards, which drive innovation in immunotherapy; the FL Biomarker Discovery Program, which advances techniques to identify and understand biomarkers related to FL; and PETReA Plus, which aims to develop better treatments that cure FL patients and avoid unnecessary toxic therapies. Its annual giving is £1,094,727.
What they fund
Priority Areas
The foundation funds research into follicular lymphoma (FL), with a focus on innovative, high-impact work that can accelerate treatment advances and a cure. Its CURE FL awards support pre-clinical and early-phase clinical research, particularly cellular immunotherapy and targeted therapies, and favour projects with potential to move into clinical trials or be applied directly to patient treatment in the near term. The FL Biomarker Discovery Program backs work to identify and understand biomarkers, improve patient stratification and enable more precise, personalised therapies. The foundation seeks projects aligned with patient needs and interests, drawing on review by global scientific and clinical experts and people living with FL. Its wider objectives include basic and translational research, patient advocacy and education, developing patient communities, and evaluating patient-reported outcomes so that patients' experiences inform better treatments.
Themes
- Follicular lymphoma research
- Cellular immunotherapy
- Targeted therapies
- Biomarker research
Geographic Focus
Priority: International.
How to apply
The CURE FL programme calls for transformative projects in treatment areas identified as most likely to deliver rapid progress towards a cure.
Application success factors
What the charity says:
- Projects are assessed for their potential to enter a clinical trial or be applied directly to patient treatment in the near term.
- The foundation encourages high-impact projects and cross-functional or organisational teams.
- Awardees are chosen with input from global experts and patients, whose views and experiences inform treatment development.
- Proposals should align with patient needs and interests.
Where they fund
Where it says it funds
- International
Similar funders
Funders supporting work similar to Follicular Lymphoma Foundation.
Five years of accounts
| Financial year | Income | Expenditure | Grants paid | Accounts document |
|---|---|---|---|---|
| year to 31 December 2020 | £380,322 | £288,427 | — | Accounts for year to 31 December 2020 |
| year to 31 December 2021 | £1,678,822 | £635,734 | — | Accounts for year to 31 December 2021 |
| year to 31 December 2022 | £2,186,260 | £2,410,165 | £1,035,795 | Accounts for year to 31 December 2022 |
| year to 31 December 2023 | £2,068,654 | £1,979,820 | £528,184 | Accounts for year to 31 December 2023 |
| year to 31 December 2024 | £2,391,779 | £2,416,517 | £1,094,727 | Accounts for year to 31 December 2024 |
Income vs grants paid
IncomeGrants paid
Total value each financial year
Grants paid stayed within income across the 3 years shown.
- Grants paid, year to 31 December 2022; year to 31 December 2023; year to 31 December 2024: grants to institutions, as reported on the charity register (Part B).
— No grants figure for that year.
Figures from the charity’s filed accounts and its register entry. The document icon links to the charity’s entry on the Charity Commission register, where its filed accounts can be found.
Sources
Registers and filings
Other sources
- theflf.org/our-research/our-funded-research-programs/cure-fl-programs · read on 30 October 2026
- theflf.org/our-research · read on 30 October 2026
- theflf.org/our-research/our-funded-research-programs/fl-biomarker-discovery-program · read on 30 October 2026
- theflf.org · read on 30 October 2026
- Annual report (year to 31 December 2024)
This profile draws on the funder’s own website as well as its filed accounts.
Sources last checked on 30 October 2026.
🎯 You've done the research. Now write an application they can't refuse.
Hinchilla combines funder's specific priorities with your organisation's past successful grants and AI analysis of what reviewers want to see.
Data privacy and security by default
Your organisation's past successful grants and experience
AI analysis of what reviewers want to see
A compelling draft application in 10 minutes instead of 10 hours
Spotted something that needs correcting? Let us know
At a glance
Applying to Follicular Lymphoma Foundation?
Hinchilla drafts your answers around this funder's priorities, using your organisation's own documents.
No credit card required
Applying to Follicular Lymphoma Foundation?
Hinchilla drafts your answers around this funder's priorities, using your organisation's own documents.
No credit card required